Irinotecan in relapsed or refractory non-Hodgkin's lymphomas. Indications of activity in a phase II trial.

A. H. Sarris, A. Phan, A. Goy, J. Romaguera, F. B. Hagemeister, M. A. Rodriguez, P. McLaughlin, B. Pro, L. J. Medeiros, Barry Samuels, O. Mesina, A. W. Bleyer, F. Cabanillas

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Irinotecan in relapsed or refractory non-Hodgkin's lymphomas. Indications of activity in a phase II trial.'. Together they form a unique fingerprint.

Medicine & Life Sciences